AI English summary of an SEC filing — figures as filed
GE HealthCare GEHCGE HealthCare said total revenues for the quarter ended March 31, 2025 were $4,777 million, growing 3% as reported and 4% organically. Sales of products increased 2% or $71 million, and sales of services increased 3% or $56 million.
Key points
AI summaryGE HealthCare said total revenues for the quarter ended March 31, 2025 were $4,777 million, growing 3% as reported and 4% organically. Sales of products increased 2% or $71 million, and sales of services increased 3% or $56 million.
The company said operating income for the quarter was $629 million, an increase of $89 million, and net income attributable to GE HealthCare was $564 million with a net income margin of 11.8%, an increase of $190 million. It cited the revaluation of its 50% interest in Nihon Medi-Physics Co., Ltd as a primary driver of the $107 million increase in other income – net.
GE HealthCare said cash from operating activities for the quarter was $250 million, a decrease of $169 million compared with the prior year period. The company cited the shift of most annual compensation payments from Q2 to Q1 and an increase in inventory as factors, and said free cash flow was $98 million.
The company said it used $269 million for investing activities during the quarter, net of cash acquired, for the acquisition of the remaining 50% interest in Nihon Medi-Physics Co., Ltd, and the Board approved a share repurchase program of up to $1,000 million on April 30, 2025.
Key figures
Quarter ended March 31, 2025
- Revenue
- $4.8B
- Operating income
- $629M
- Net income
- $564M
- EPS
- $1.23
- Gross profit
- $2.0B
- Operating cash flow
- $250M
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed the Management's Discussion and Analysis (MD&A) section. Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Q1 2025 Total Revenues $4,777 million
GE HealthCare said total revenues for the quarter ended March 31, 2025 were $4,777 million, growing 3% as reported and 4% organically. Sales of products increased 2% or $71 million, and sales of services increased 3% or $56 million.
Source · Based on the MD&A text of the filing
Operating Income $629 million, Net Income $564 million
The company said operating income for the quarter was $629 million, an increase of $89 million, and net income attributable to GE HealthCare was $564 million with a net income margin of 11.8%, an increase of $190 million. It cited the revaluation of its 50% interest in Nihon Medi-Physics Co., Ltd as a primary driver of the $107 million increase in other income – net.
Source · Based on the MD&A text of the filing
Operating Cash Flow $250 million, Free Cash Flow $98 million
GE HealthCare said cash from operating activities for the quarter was $250 million, a decrease of $169 million compared with the prior year period. The company cited the shift of most annual compensation payments from Q2 to Q1 and an increase in inventory as factors, and said free cash flow was $98 million.
Source · Based on the MD&A text of the filing
NMP Acquisition and $1,000 million Share Repurchase Authorization
The company said it used $269 million for investing activities during the quarter, net of cash acquired, for the acquisition of the remaining 50% interest in Nihon Medi-Physics Co., Ltd, and the Board approved a share repurchase program of up to $1,000 million on April 30, 2025.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…